HERON THERAPEUTICS, INC. /DE/ Deferred Tax Liabilities, Gross
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Deferred Tax Liabilities, Gross of $0 as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-26
- 2025-12-31: Deferred Tax Liabilities, Gross $0.00.
- 2024-12-31: Deferred Tax Liabilities, Gross $699.00K.
- 2023-12-31: Deferred Tax Liabilities, Gross $1.36M.
- 2022-12-31: Deferred Tax Liabilities, Gross $1.91M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | $699.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $1.36M 10-K · filed 2025-02-27 |
| 2022-12-31 | $1.91M 10-K · filed 2024-03-12 |
| 2021-12-31 | $2.42M 10-K · filed 2023-03-29 |
| 2020-12-31 | $4.01M 10-K · filed 2022-02-28 |
| 2019-12-31 | $3.38M 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |